Skip to content
Can biotech crack the code on pain medications?
Pain is the number one reason most Americans go to the doctor is pain, says Cindy Steinberg, Director of Policy and Advocacy for the […]
Can biotech crack the code on pain medications? Read More »
Latest News
Will gene therapies for ultra-rare diseases become a cautionary tale – or life-saving products?
For three decades, Genethon, a non-profit research organization, has pioneered development of gene therapies for rare and ultra-rare diseases. Now that our hard work
The rise of drug-resistant Shigella offers glimpse into danger AMR poses
A significant increase in the percentage of Shigella infections caused by extensively drug-resistant (XDR) versions of the bacteria has prompted the U.S. Centers for
The rise of drug-resistant Shigella offers glimpse into danger AMR poses Read More »
USDA Agricultural Outlook Forum: SAF, carbon markets, and the future of biotechnology
The U.S. Department of Agriculture (USDA) held the 99th Agricultural Outlook Forum last week, where many speakers highlighted the potential of biotechnology and bio-based products.
USDA Agricultural Outlook Forum: SAF, carbon markets, and the future of biotechnology Read More »
Biosimilars expected to boom in 2023-27, says report
According to a recent report from IQVIA, the market for biosimilars, which mimic innovative biologics, is poised to grow this year. Since 2007, a
Biosimilars expected to boom in 2023-27, says report Read More »
Gilead’s anti-COVID Veklury reduces risk of death
Starting Veklury (remdesivir) within the first two days of hospitalization for COVID-19 can reduce mortality and decrease readmission rates for all hospitalized patients, regardless
Gilead’s anti-COVID Veklury reduces risk of death Read More »
Pfizer’s RSV vaccine for infants could be approved this summer
Pfizer’s vaccine aimed at protecting infants against severe respiratory syncytial virus (RSV) could roll out as early as this summer as the Food and
Pfizer’s RSV vaccine for infants could be approved this summer Read More »
Acceligen’s gene-edited calf less susceptible to BVDV
Biotechnology Innovation Organization (BIO) member Acceligen partnered with the USDA’s Agricultural Research Service to develop gene-edited cattle resistant to bovine viral diarrhea (BVD), a
Acceligen’s gene-edited calf less susceptible to BVDV Read More »
NCBA understands that, in Black America, health care is holistic
“You know,” Karyne Jones laughs, “I am about the same age as many of the people I work with, so the older I get,
NCBA understands that, in Black America, health care is holistic Read More »
Biotech helps to fight climate change with carbon-devouring GM trees
A California biotech company seeking to help fight climate change is using the power of plants to create a new tool for that fight:
Biotech helps to fight climate change with carbon-devouring GM trees Read More »